Cargando…
Differences in the effects of anxiolytics bromodihydrochlorophenylbenzodiazepine and fabomotizole in patients with anxiety disorders in dependence on their individually-typological features
INTRODUCTION: Personalized approach in drug therapy is an essential line of modern psychiatry. Experimental and clinical studies of anxiolytics have shown differences in drug effects in dependence on genetically determined reactions to stress and personal features. OBJECTIVES: To evaluate of the the...
Autores principales: | Dorofeeva, O., Metlina, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566789/ http://dx.doi.org/10.1192/j.eurpsy.2022.987 |
Ejemplares similares
-
Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole
por: Voronin, Mikhail V., et al.
Publicado: (2021) -
Clinical effects of central antagonist of cholecystokinin-1 receptors GB-115 in patients with Generalized Anxiety Disorder
por: Dorofeeva, O., et al.
Publicado: (2022) -
Impact of central antagonist of cholecystokinin-1 receptors GB-115 on cognitive functions in patients with Generalized Anxiety Disorder
por: Dorofeeva, O., et al.
Publicado: (2022) -
The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
por: Strawn, Jeffrey R, et al.
Publicado: (2007) -
Spatial typologies in psychiatric facilities
por: Kirch, J.
Publicado: (2023)